Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor κB by black raspberry extracts

Cancer Research

Volumn 62, Issue 23, 2002, Pages 6857-6863

  Huang, Chuanshu ^a   Huang, Yi ^a   Li, Jingxia ^a   Hu, Wenwei ^a   Aziz, Robeena ^b   Tang, Moon shong ^a   Sun, Nanjun ^b   Cassady, John ^b   Stoner, Gary D ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLACK RASPBERRY EXTRACT; DIHYDROXYBENZO[A]PYRENE OXIDE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHANOL; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; EPIDERMIS CELL; EXTRACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RASPBERRY; TRANSACTIVATION;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ANIMALS; CARCINOGENS; CELL LINE; DNA ADDUCTS; DRUG INTERACTIONS; ENZYME ACTIVATION; EPIDERMIS; FRUIT; I-KAPPA B PROTEINS; METHANOL; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHORYLATION; PLANT EXTRACTS; ROSACEAE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1;

EID: 0036894353     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Block, G., Patterson, B., and Subar, A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr. Cancer, 18: 1-29, 1992.
2. Steinmetz, K. A., and Potter, J. D. Vegetables, fruit, and cancer prevention: A review. J. Am. Diet. Assoc., 96: 1027-1039, 1996.
3. Rijken, P. J., Timmer, W. G., van de Kooij, A. J., van Benschop, I. M., Wiseman, S. A., Meijers, M., and Tijburg, L. B. M. Effect of vegetable and carotenoid consumption on aberrant crypt multiplicity, a surrogate end-point marker for colorectal cancer in azoxymethane-induced rats. Carcinogenesis (Lond.), 20: 2267-2272, 1999.
4. Okajima, E., Tsutsumi, M., Ozono, S., Akai, H., Denda, A., Nishino, H., Oshima, S., Sakamoto, H., and Konishi, Y. Inhibitory effect of tomato juice on rat urinary bladder carcinogenesis after N-butyl-N-(4-hydroxy-butyl)nitrosamine initiation. Jpn. J. Cancer Res., 89: 22-26, 1998.
5. Narisawa, T., Fukaura, Y., Hasebe, M., Nomura, S., Oshima, S., Sakamoto, H., Inakuma, T., Ishiguro, Y., Takayasu, J., and Nishino, H. Prevention of N-methylnitrosourea-induced colon carcinogenesis in F344 rats by lycopene and tomato juice rich in lycopene. Jpn. J. Cancer Res., 89: 1003-1008, 1998.
6. Narisawa, T., Fukaura, Y., Hasebe, M., Nomura, S., Oshima, S., and Inakuma, T. Prevention of N-methylnitrosourea-induced colon carcinogenesis in rats by oxygenated carotenoid capsanthin-rich paprika juice. Proc. Soc. Exp. Biol. Med., 224: 116-122, 2000.
7. Hughes, J. S., Ganthavorn, C., and Wilson-Sanders, S. Dry beans inhibit azoxymethane-induced colon carcinogenesis in F344 rats. J. Nutr., 127: 2328-2333, 1997.
8. Schaffer, E. M., Liu, J. Z., Green, J., Dangler, C. A., and Milner, J. A. Garlic and associated allyl sulfur components inhibit N-methyl-N-nitrosourea induced rat mammary carcinogenesis. Cancer Lett., 102: 199-204, 1996.
9. Gotoh, T., Yamada, K., Yin, H., Ito, A., Kataoka, T., and Dohi, K. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn. J. Cancer Res., 89: 137-142, 1998.
10. Stoner, G. D., Kresty, L. A., Carlton, P. S., Siglin, J. C., and Morse, M. A. Isothiocyanates and freeze-dried strawberries as inhibitors of esophageal cancer. Toxicol. Sci., 52(2 Suppl.):95-100, 1999.
11. Carlton, P. S., Kresty, L. A., Siglin, J. C., Morse, M. A., Lu, J., Morgan, C., and Stoner, G. D. Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis (Lond.), 22: 441-446, 2001.
12. Kresty, L. A., Morse, M. A., Morgan, C., Carlton, P. S., Lu, J., Gupta, A., Blackwood, M., and Stoner, G. D. Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res., 61: 6112-6119, 2001.
13. Harris, G. K., Gupta, A., Nines, R. G., Kresty, L. A., Habib, S. G., Frankel, W. L., LaPerle, K., Gallaher, D. D., Schwartz, S. J., and Stoner, G. D. Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2′-deoxyguanosine levels in the Fischer 344 rat. Nutr. Cancer, 40: 125-133, 2001.
14. Xue, H., Aziz, R. M., Sun, N., Cassady, J. M., Kamendulis, L. M., Xu, Y., Stoner, G. D., and Klaunig. J. E. Inhibition of cellular transformation by berry extracts. Carcinogenesis (Lond.), 22: 351-356, 2001.
15. Licato, L. L., and Brenner, D. A. Analysis of signaling protein kinases in human colon or colorectal carcinomas. Dig. Dis. Sci., 43: 1454-1464, 1998.
16. Mandal, M., Olson, D. J., Sharma, T., Vadlamudi, R. K., and Kumar, R. Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology, 120: 71-78. 2001.
17. Dong, Z., Watts, R. G., Sun, Y., and Colburn, N. H. Progressive elevation of AP-1 activity during preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Int. J. Oncol., 7: 359-364, 1995.
18. Dong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M., and Colburn, N. H. Blocking tumor promoter induced AP-1 activity inhibits induced transformation in JB6 cells. Proc. Natl. Acad. Sci. USA. 91: 609-613, 1994.
19. Bernstein, L. R., and Colburn, N. H. AP-1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science (Wash. DC), 244: 566-569, 1989.
20. Huang, C., Ma, W-Y., Colburn, N., and Dong, Z. The shortage of mitogen-activated protein (MAP) kinase is responsible for the tumor promotion resistant (P-) phenotype of JB6 cells. Proc. Natl. Acad. Sci. USA, 95: 156-161, 1998.
21. Watts, R. G., Huang, C., Young, M. R., Li, J. J., Dong, Z., Pennie, W. D., and Colburn, N. H. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene, 17: 3493-3498, 1998.
22. Huang, C., Ma, W-Y., Dawson, M. I., Rincon, M., Flavell, R. A., and Dong, Z. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc. Natl. Acad. Sci. USA, 94: 5826-5830, 1997.
23. Huang, C., Ma, W-Y., Ryan, C. A., and Dong, Z. Proteinase inhibitors I and II from potatoes specifically block UV-induced activator protein-1 activation through a pathway that is independent of extracellular signal-regulated kinases, c-Jun N-terminal kinases, and P38 kinase. Proc. Natl. Acad. Sci. USA. 94: 11957-11962, 1997.
24. Huang, C., Ma, W-Y., Hecht, S. S., and Dong, Z. Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3′ kinase. Cancer Res., 57: 2873-2878, 1997.
25. Huang, C., Chen, N., Ma, W-Y., and Dong, Z. Vanadium induces AP-1 and NF′ B-dependent transcription activity. Int. J. Oncol., 13: 711-715, 1998.
26. Angel, P., and Karin, M. The role of Jun. Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
27. Manna, S. K., and Aggarwal, B. B. Wortmannin inhibits activation of nuclear transcription factors NF-′B and activated protein-1 induced by lipopolysaccharide and phorbol ester. FEBS Lett., 473: 113-118, 2000.
28. Baldwin, A. The NF-′B and I′B proteins: New discoveries and insights. Annu. Rev. Immunol., 14: 649-683, 1996.
29. Ghosh, S., May, M. J., and Kopp, E. B. NF-′B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol., 16: 225-260, 1998.
30. Li, J. J., Westergaard, C., Ghosh, P., and Colburn, N. H. Inhibitors of both nuclear factor-′B and activator protein-1 activation block the neoplastic transformation response. Cancer Res., 57: 3569-3576, 1997.
31. Gilmore, T. D., Koedood, M., Piffat, K. A., and White, D. W. Rel/NF-′B/I′B proteins and cancer. Oncogene, 13: 1367-1378, 1996.
32. Baeuerle, P. A., and Baltimore, D. NF-′ B: Ten years after. Cell, 87: 13-20, 1996.
33. Galang, C. K., Garcia-Ramirez, J., Solski, P. A., Westwick, J. K., Der, C. J., Neznanov, N. N., Oshima, R. G., and Hauser, C. A. Oncogenic Neu/ErbB-2 increases Ets. AP-1, and NF-′B-dependent gene expression, and inhibiting Ets activation blocks Neu-mediated cellular transformation. J Biol. Chem., 271: 7992-7998, 1996.
34. Finco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J., and Baldwin, A. S., Jr. Oncogenic Ha-Ras-induced signaling activates NF-′ B transcriptional activity, which is required for cellular transformation. J. Biol. Chem., 272: 24113-24116, 1997.
35. Karin, M., Liu, Z., and Zandi, E. AP-1 function and regulation. Curr. Opin. Cell Biol., 9: 240-246, 1997.
36. Huang, C., Ma, W-Y., and Dong, Z. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol. Cell. Biol., 16: 6427-6435, 1996.
37. Sayer, J. M., Yagi, H., Wood, A., Conney, A. H., and Jerina, D. M. Extremely facile reaction between the ultimate carcinogen benzo(a)pyrene-7, 8-diol 9, 10-epoxide and ellagic acid. J. Amer. Chem. Soc., 104: 5562-5564, 1982.
38. Conney, A. H., Chang, R. L., Jerina, D. M., and Wei, S-J. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev., 26: 125-163, 1994.
39. Shimada, T., Gillam, E. M. J., Oda, Y., Tsumura, F., Sutter, T. R., Guengerich, F. P., and Inoue, K. Metabolism of benzo[a]pyrene to trans-7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 IB1 and purified liver epoxide hydrolase. Chem. Res. Toxicol., 12: 623-629, 1999.
40. Cooper, C. S., Grover, P. L., and Sims, P. The metabolism and activation of benzo(a)pyrene. Prog. Drug. Metab., 7: 295-396, 1983.
41. Slaga, T. J., Bracken, W. J., Gleason, G., Levin, W., Yagi, H., Jerina, D. M., and Conley, A. H. Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo[a]pyrene 7, 8-diol-9, 10-epoxides. Cancer Res., 39: 67-71, 1979.
42. Levin, W., Wood, A. W., Yagi, H., Jerina, D. M., and Conney, A. H. (±)-trans-7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene: A potent skin carcinogen when applied topically to mice. Proc. Natl. Acad. Sci. USA, 73: 3867-3871, 1976.
43. Bresnik, E., McDonald, T. F., Yagi, H., Jerina, D. M., Levin, W., Wood, A. W., and Conney, A. H. Epidermal hyperplasia after topical application of benzo[a]pyrene, benzo[a]pyrene diol epoxides, and other metabolites. Cancer Res., 37: 984-990, 1977.
44. Albert, R. E., Miller, M. L., Cody, T., Andringa, A., Shukla, R., and Baxter, C. S. Benzo[a]pyrene-induced skin damage and tumor promotion in the mouse. Carcinogenesis (Lond.), 12: 1273-1280, 1991.
45. DiGiovanni, J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther., 54: 63-128, 1992.
46. Bral, C. M., and Ramos, K. S. Identification of benzo[a]pyrene-inducible cis-acting elements within c-Ha-ras transcriptional regulatory sequences. Mol. Pharmacol., 52: 974-982, 1997.